Erector Spinae Block Versus Thoracic Paravertebral Block for Acute Thoracic Herpes Zoster

Last updated: December 6, 2020
Sponsor: Tanta University
Overall Status: Active - Recruiting

Phase

4

Condition

Chickenpox (Varicella Zoster Infection)

Herpes Simplex Infections

Rash

Treatment

N/A

Clinical Study ID

NCT04656821
32720/11/18
  • Ages 51-75
  • All Genders

Study Summary

The aim of this research is to study and compare the efficacy and safety of single injection erector spinae plane block and thoracic paravertebral block in prevention of post herpetic neuralgia in patients with acute thoracic herpes zoster.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Over 50 years of age
  • Chest wall herpetic eruption of less than one week
  • Moderate or severe pain

Exclusion

Exclusion Criteria:

  • Patient refusal
  • Eruption more than one week duration
  • Patients who will not receive appropriate anti-viral therapy
  • Patients with mild pain
  • Infection at the site of injection
  • Patients with a history of renal, hepatic diseases, coagulopathy, steroid therapy,malignancies.
  • Patient taking chemotherapy and/or radiotherapy.

Study Design

Total Participants: 90
Study Start date:
December 05, 2020
Estimated Completion Date:
June 20, 2021

Connect with a study center

  • Tanta University Hospitals

    Tanta,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.